{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:51:20Z","timestamp":1792097480814,"version":"4.4.0"},"reference-count":24,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1210\/jc.2005-0742","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T22:28:36Z","timestamp":1126132116000},"page":"5324-5328","source":"Crossref","is-referenced-by-count":29,"title":["Circulating Resistin Levels Are Not Associated with Fat Redistribution, Insulin Resistance, or Metabolic Profile in Patients with the Highly Active Antiretroviral Therapy-Induced Metabolic Syndrome"],"prefix":"10.1210","volume":"90","author":[{"given":"Diana","family":"Barb","sequence":"first","affiliation":[{"name":"Divisions of Endocrinology, Diabetes, and Metabolism (D.B., A.G., J.L.C., C.J.W., C.S.M.), Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjivini G.","family":"Wadhwa","sequence":"additional","affiliation":[{"name":"Infectious Disease (S.G.W., A.W.K.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Kratzsch","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig (J.K.), 04109 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Gavrila","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology, Diabetes, and Metabolism (D.B., A.G., J.L.C., C.J.W., C.S.M.), Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Chan","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology, Diabetes, and Metabolism (D.B., A.G., J.L.C., C.J.W., C.S.M.), Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Williams","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology, Diabetes, and Metabolism (D.B., A.G., J.L.C., C.J.W., C.S.M.), Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolf W.","family":"Karchmer","sequence":"additional","affiliation":[{"name":"Infectious Disease (S.G.W., A.W.K.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology, Diabetes, and Metabolism (D.B., A.G., J.L.C., C.J.W., C.S.M.), Boston, Massachusetts 02215;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041115530253800_R1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults.","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041115530253800_R2","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jc.2002-021704","article-title":"Clinical review 159: Human immunodeficiency virus\/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies.","volume":"88","author":"Leow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R3","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"2019041115530253800_R4","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1074\/jbc.M408687200","article-title":"Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines.","volume":"280","author":"Vernochet","year":"2005","journal-title":"J Biol Chem"},{"key":"2019041115530253800_R5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes.","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"2019041115530253800_R6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2796.2004.01306.x","article-title":"The current biology of resistin.","volume":"255","author":"Steppan","year":"2004","journal-title":"J Intern Med"},{"key":"2019041115530253800_R7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI20785","article-title":"Adenovirus-mediated chronic \u201chyper-resistinemia\u201d leads to in vivo insulin resistance in normal rats.","volume":"114","author":"Satoh","year":"2004","journal-title":"J Clin Invest"},{"key":"2019041115530253800_R8","doi-asserted-by":"crossref","first-page":"25651","DOI":"10.1074\/jbc.C100189200","article-title":"Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor \u03b3 agonists.","volume":"276","author":"Way","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041115530253800_R9","first-page":"E625","article-title":"Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia","volume":"288","author":"Lee","year":"2005","journal-title":"Am J Physiol."},{"key":"2019041115530253800_R10","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/jc.2002-021808","article-title":"Serum resistin (FIZZ3) protein is increased in obese humans.","volume":"88","author":"Degawa-Yamauchi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/jc.2003-031121","article-title":"Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus.","volume":"89","author":"Youn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1490331","article-title":"Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.","volume":"149","author":"Silha","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2019041115530253800_R13","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R14","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jc.2003-031410","article-title":"Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects.","volume":"89","author":"Heilbronn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diabetes.53.5.1279","article-title":"High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.","volume":"53","author":"Vozarova de Court, Degawa-Yamauchi","year":"2004","journal-title":"Diabetes"},{"key":"2019041115530253800_R16","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1210\/jc.2005-0287","article-title":"Resistin levels in HIV-infected patients with lipoatrophy decrease in response to rosiglitazone.","volume":"90","author":"Kamin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.","volume":"88","author":"Addy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin.","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2019041115530253800_R19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.ijo.0802625","article-title":"Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.","volume":"28","author":"Bajaj","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041115530253800_R20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/MCB.25.4.1569-1575.2005","article-title":"Activation of SOCS-3 by resistin.","volume":"25","author":"Steppan","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2019041115530253800_R21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1210\/jc.2002-021604","article-title":"Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.","volume":"88","author":"Yannakoulia","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R22","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2337\/diabetes.51.9.2734","article-title":"Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.","volume":"51","author":"Nishizawa","year":"2002","journal-title":"Diabetes"},{"key":"2019041115530253800_R23","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1210\/jcem.87.5.8627","article-title":"Increased resistin gene and protein expression in human abdominal adipose tissue.","volume":"87","author":"McTernan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115530253800_R24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0006-291X(02)02864-4","article-title":"Resistin release by human adipose tissue explants in primary culture.","volume":"300","author":"Fain","year":"2003","journal-title":"Biochem Biophys Res Commun"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/90\/9\/5324\/10777384\/jcem5324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T05:40:04Z","timestamp":1555047604000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/90\/9\/5324\/2838715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2005-0742","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,1]]}}}